(Q35007178)

5 August 2017

Clinicopathological characteristics and her-2/neu status in chinese patients with uterine papillary serous carcinoma (English)

1 reference

5 August 2017

1 reference

Yulan Ren

1

1 reference

5 August 2017

Huaying Wang

2

1 reference

5 August 2017

Xiaoyan Zhou

3

1 reference

5 August 2017

Wentao Yang

4

1 reference

5 August 2017

Xiaowei Huang

5

1 reference

5 August 2017

Yongming Lu

6

1 reference

5 August 2017

Daren Shi

7

1 reference

5 August 2017

20 October 2010

1 reference

ISRN Obstetrics & Gynecology

5 August 2017

1 reference

5 August 2017

2011

1 reference

5 August 2017

575327

1 reference

Creative Commons Attribution 3.0 Unported

5 August 2017

start time

20 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Molecular and pathologic aspects of endometrial carcinogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Role of HER receptors family in development and differentiation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Treatment of uterine papillary serous carcinoma with paclitaxel

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Cancer incidence trends in urban shanghai, 1972-1994: an update

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Two pathogenetic types of endometrial carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

8 July 2018

1 reference

https://api.crossref.org/works/10.5402%2F2011%2F575327

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2011%2F575327

Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2011%2F575327

Effect of oral administration of clinically relevant doses of dexamethasone on regulation of cytochrome P450 subfamilies in hepatic microsomes from dogs and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2011%2F575327

Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2011%2F575327

HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.5402%2F2011%2F575327

Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Overexpression of HER-2/neu in uterine serous papillary cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3102014

HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients

26 October 2018

1 reference

12 December 2020

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content

1 reference

12 December 2020

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

12 December 2020

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

1 reference

12 December 2020

Clinical significance of Her-2/neu overexpression in uterine serous carcinoma

1 reference

12 December 2020

[Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma]

1 reference

12 December 2020

New gynecologic cancer staging

1 reference

12 December 2020

Identifiers

DOI

10.5402/2011/575327

1 reference

5 August 2017

1 reference

5 August 2017

1 reference